Navigation Links
The European IVF Monitoring Group celebrates its 10-year anniversary
Date:8/4/2010

Reasons why you should attend this workshop:

  • Opportunities for in-depth interviews and discussions with key players in Assisted Reproduction Technologies (ART) data monitoring in Europe and beyond
  • You will hear different aspects of ART monitoring:
    • An overview of ART data in Europe
    • Use of ART data from Europe and the world what have we learned?
    • Possibilities and limitations of pooling ART infant outcome data from different countries
    • The validity of voluntary registers for cross border patients
    • Different experiences from specific countries for example Turkey and Russia
    • National developments such as the French public health register, digital recording in Germany and the data disclosure system in the UK
    • Future vision of the EIM

The target audience for this meeting is professionals working in ART, that are interested in public health questions and national/regional data collection, as well as public health professionals interested in infertility treatments, at national and European level.

You can find more information on this event here: http://www.eshre.eu/ESHRE/English/Calendar/Eshre-campus/EIM-10-years-celebration-meeting/page.aspx/1039

You are welcome to register for the symposium before 6 September 2010. Although you can register onsite, pre-registration allows us to iron out any queries.

Reproductive medicine is one of today's most exciting scientific and clinical areas. Every month brings announcements of research developments, medical 'firsts', new rulings by regulatory bodies, or ethical controversies often sparking a heated debate among practitioners in the field, ethicists, legislators, the media and the public.

FOR THE MEDIA

ESHRE offers support to journalists that wish to attend this meeting. Bona fide journalists, in possession of a recognized press card or a commissioning letter on headed paper from the publication they are working for, may register for free. Journalists are required to observe embargoes as indicated either by ESHRE staff or by the date/time of the presented session.

All sessions are open to the media. The official language of the course is English.


'/>"/>

Contact: Hanna Hanssen
hanna@eshre.eu
32-473-353-381
European Society of Human Reproduction and Embryology
Source:Eurekalert

Related biology news :

1. IOF calls on European citizens to stand tall and speak out for their bones
2. IronKey Opens New European Office
3. European researchers harness unique properties of boron to develop new drugs and diagnostics
4. Vidaza receives positve opinion from European CHMP
5. The MDS foundation supports vidazas recommendation for European approval
6. European biodiversity and ecosystem scientists merge and gear up for long-term research
7. Overfishing threatens European bluefin tuna
8. European ancestry increases breast cancer risk among Latinas
9. IRB Barcelona to coordinate two European projects on biomedicine
10. Key to future medical breakthroughs is systems biology, say leading European scientists
11. Global warming linked to European viral epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2016)... , Nov. 21, 2016   Neurotechnology ... object recognition technologies, today announced that the MegaMatcher ... cards was submitted for the NIST Minutiae ... passed all the mandatory steps of the evaluation ... is a continuing test of fingerprint templates used ...
(Date:11/17/2016)... 17, 2016 Global Market Watch: Primarily ... Banks, Population-Based Banks and Academics) market is to witness a ... Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of ... during the analysis period 2014-2020. North America ... followed by Europe at 9.56% respectively. ...
(Date:11/16/2016)... Nov. 16, 2016 Sensory Inc ., ... security for consumer electronics, and VeriTran , ... retail industry, today announced a global partnership that ... to authenticate users of mobile banking and mobile ... software which requires no specialized biometric scanners, ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... N.J. , Dec. 8, 2016  Soligenix, ... late-stage biopharmaceutical company focused on developing and commercializing ... an unmet medical need, announced today the long-term ... with SGX942 (dusquetide), a first-in-class Innate Defense Regulator ... in head and neck cancer patients undergoing chemoradiation ...
(Date:12/8/2016)... 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a ... plans to commercialize innovative therapeutics for patients with ... were approved for trading on the OTCQX U.S. ... OTCQX, effective today, under the ticker symbol "HPPI." ... companies must meet high financial standards, follow best ...
(Date:12/8/2016)... Dec. 8, 2016 Eutilex Co. Ltd. today ... (US $18.9M) Series A financing. This financing round included ... Venture and SNU Bio Angel. This new funding brings ... KRW (US $27.7M) since its founding in 2015. ... the development and commercialization of its immuno-oncology programs, expand ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... ), a leading commercial provider of clinically actionable ... cancer patients, announces that clinical data featuring its ... concordance to tissue biopsy for the detection of ... The results from research sponsored by Sara Cannon ...
Breaking Biology Technology: